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Detecting
Clostridium 
botulinum
To the Editor: In the October
2005 issue of Emerging Infectious
Diseases, Song et al. described a
fiber-optic, microsphere-based, high-
density array composed of 18 species-
specific probe microsensors, used to
identify biological warfare agents,
including Clostridium botulinum (1).
Although the researchers used multi-
ple probes for C. botulinum, we doubt
that this approach is suitable for this
organism.
C. botulinum comprises a heteroge-
nous group of subspecies that produce
botulinum neurotoxin (BoNT); identi-
fication and characterization usually
rely on animal testing that focuses on
antigenetically distinct toxins (2).
Although strains of C. botulinum that
do not produce toxins are sometimes
isolated from wound infections not
related to botulism, some strains of C.
butyricum and C. baratii are also able
to produce BoNTs.
The mouse bioassay is currently
the accepted method for detecting
BoNT. In this assay, mice that receive
an intraperitoneal injection containing
a sample with more than a minimum
lethal dose show symptoms of botu-
linum intoxication and die. ELISAs,
which recognize protein antigenic
sites, are still less sensitive than the
mouse bioassay (3).
Because the mouse bioassay
requires euthanizing many animals,
and results are not available for sev-
eral hours, new diagnostic methods
are needed. For C. botulinum, an
organism widely dispersed in the
environment, DNA-based methods
may not provide the ultimate solu-
tion. Rapid methods to detect and dif-
ferentiate active BoNTs, such as the
rapid, mass spectrometry-based,
functional method, are promising
candidates to substitute for animal
testing in the near future (4).
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Echinococcus 
multilocularis in
Dogs, Japan
To the Editor: Alveolar echino-
coccosis in humans is endemic in
Japan; however, the causal agent,
Echinococcus multilocularis, has
been restricted to the northernmost
insular prefecture of Hokkaido, where
the Tsugaru Strait acts as a natural
physical barrier against migration to
the mainland. Two E. multilocularis
invasions into Hokkaido have
occurred (1). The first invasion to the
offshore island of Rebun in the mid-
1920s was successfully controlled;
however, the second invasion, sup-
posedly in the 1940s, led to the cur-
rent epidemic on the main island of
Hokkaido. Both invasions were
entirely or partly caused by humans
who removed foxes from disease-
endemic areas without taking the nec-
essary precautions.
The finding of 19 autochthonously
acquired cases of alveolar echinococ-
cosis in prefectures other than
Hokkaido (2) implies that the parasite
exists in other areas, although the
source of infection has yet to be iden-
tified. In many countries, studies of
the increased spread of the parasite
have traditionally focused on the con-
tribution of foxes (3); however, these
cases may also have been spread by
domestic dogs from disease-endemic
areas. Dogs are susceptible to infec-
tion with the parasite from rodents.
Although the prevalence of E. multi-
locularis among dogs in Hokkaido is
certainly lower than that in foxes
(4–6), dogs can traverse considerably
greater distances by various modes of
transport. The number of dogs that
travel from Hokkaido to other prefec-
tures has been estimated at >12,000
per year (7). Although dogs may
carry the parasite to remote areas, sur-
veys of population dynamics have not
been undertaken. We therefore stud-
ied the extent of E. multilocularis
infection in dogs being transported by
their owners from 4 ferry ports in
Hokkaido (Hakodate, Muroran,
Otaru, and Tomakomai) from Sep-
tember 2003 through October 2004. 
We tested 183 fecal samples from
41 resident (in Hokkaido) and 142
nonresident dogs. We screened for the
Echinococcus-specific coproantigen
by using a commercial enzyme-linked
immunosorbent assay kit (CHEKIT-
Echinotest, Bommeli Diagnostics,
Liebefeld-Bern, Switzerland) and fol-
lowing the manufacturer’s recom-
mendations. One dog from each group
had the Echinococcus coproantigen.
To confirm the specificity of the
results, these 2 dogs were treated with
1 oral dose of praziquantel, 5 mg/kg.